https://2-meoe2inhibitor.com/t....he-actual-impact-inv
We aimed to externally measure the Caprini, IMPROVE and Padua VTE risk results and to compare their overall performance to advanced age as a stand-alone predictor. PRACTICES We performed a retrospective evaluation of customers prospectively signed up for the PREVENU test. Patients elderly 40-years and older, hospitalised for at least 2-days on a medical ward were consecutively enrolled and used for 90 days. Critical ill clients are not recruited. Clients diagnosed with VTE within 48-hours
Like
Comment
Share
